Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pralatrexate in Advanced or Metastatic Breast Cancer
NCT01118624Phase 2Completed
- Sponsor
- Acrotech Biopharma Inc
- Start
- Mar 2010
- Primary completion
- Apr 2012
- Modality
- Small Molecules
- Countries
- 4
01
Overview
Phase 2, open-label, single-arm trial of pralatrexate in breast cancer, sponsored by Acrotech Biopharma Inc. Primary endpoint: Objective Response Rate. Started Mar 2010; status: completed.
02
Drugs
pralatrexate
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01118624.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01118624.